Recent Analysts’ Ratings Changes for Humana (HUM)

A number of research firms have changed their ratings and price targets for Humana (NYSE: HUM):

• 8/10/2026 – Humana had its price target raised by JPMorgan Chase & Co. from $316.00 to $393.00. They now have a “neutral” rating on the stock.
• 8/4/2026 – Humana was upgraded by Morgan Stanley from “underweight” to “equal weight”. They now have a $370.00 price target on the stock, up from $249.00.
• 7/31/2026 – Humana had its price target raised by Barclays PLC from $344.00 to $407.00. They now have an “equal weight” rating on the stock.
• 7/31/2026 – Humana had its price target raised by TD Cowen from $350.00 to $370.00. They now have a “hold” rating on the stock.
• 7/30/2026 – Humana was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 7/30/2026 – Humana was upgraded by Piper Sandler from “hold” to “overweight”. They now have a $463.00 price target on the stock.
• 7/30/2026 – Humana is now covered by UBS Group AG. They set a “buy” rating on the stock.
• 7/30/2026 – Humana was upgraded by Wolfe Research from “peer perform” to “outperform”.
• 7/30/2026 – Humana is now covered by Deutsche Bank Aktiengesellschaft. They set a “hold” rating on the stock.
• 7/30/2026 – Humana was downgraded by HSBC Holdings plc to “hold”.
• 7/30/2026 – Humana is now covered by Lake Street Capital. They set a “buy” rating on the stock.
• 7/30/2026 – Humana had its price target raised by UBS Group AG from $320.00 to $405.00. They now have a “neutral” rating on the stock.
• 7/30/2026 – Humana had its “outperform” rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $405.00 price target on the stock.
• 7/30/2026 – Humana was given a new $390.00 price target by Robert W. Baird.
• 7/30/2026 – Humana had its price target raised by Guggenheim from $269.00 to $471.00. They now have a “buy” rating on the stock.
• 7/30/2026 – Humana was downgraded by Raymond James Financial, Inc. from “outperform” to “market perform”.
• 7/30/2026 – Humana was upgraded by Leerink Partners from “market perform” to “outperform”. They now have a $513.00 price target on the stock.
• 7/29/2026 – Humana was upgraded by Evercore Inc from “in-line” to “outperform”. They now have a $480.00 price target on the stock.
• 7/29/2026 – Humana was upgraded by Bank of America Corporation from “neutral” to “buy”. They now have a $500.00 price target on the stock.
• 7/20/2026 – Humana had its “neutral” rating reaffirmed by Bank of America Corporation. They now have a $410.00 price target on the stock.
• 7/14/2026 – Humana had its price target raised by TD Cowen from $211.00 to $350.00. They now have a “hold” rating on the stock.
• 7/14/2026 – Humana had its price target raised by Truist Financial Corporation from $320.00 to $415.00. They now have a “hold” rating on the stock.
• 7/13/2026 – Humana was upgraded by Wells Fargo & Company from “equal weight” to “overweight”. They now have a $502.00 price target on the stock, up from $227.00.
• 7/13/2026 – Humana was upgraded by Zacks Research from “hold” to “strong-buy”.
• 7/9/2026 – Humana had its price target raised by Royal Bank Of Canada from $246.00 to $415.00. They now have a “sector perform” rating on the stock.
• 7/7/2026 – Humana was given a new $300.00 price target by Raymond James Financial, Inc..
• 7/7/2026 – Humana had its price target raised by Cantor Fitzgerald from $264.00 to $300.00. They now have a “neutral” rating on the stock.
• 6/29/2026 – Humana was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 6/24/2026 – Humana had its price target raised by Bank of America Corporation from $340.00 to $380.00. They now have a “neutral” rating on the stock.
• 6/15/2026 – Humana had its “neutral” rating reaffirmed by UBS Group AG.
• 6/12/2026 – Humana was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.